Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Adam Eckert

UNCOVERED: Why biogen shares are sliding today - The Untold Story

Biogen Inc (NASDAQ:BIIB) is trading lower Thursday morning after the company announced worse-than-expected fourth-quarter earnings results and issued guidance below estimates.

Biogen reported quarterly revenue of $2.73 billion, which beat the estimate of $2.62 billion. The company reported adjusted earnings of $3.39 per share, which came in below the $3.40 estimate. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.